NCT05391113

Brief Summary

An MRI Study in Subjects with Autism Spectrum Disorder and Subjects with Food Addictive Disorder compared to healthy volunteers.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Jul 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jul 2023Jan 2027

First Submitted

Initial submission to the registry

May 20, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
1.2 years until next milestone

Study Start

First participant enrolled

July 27, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2027

Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

3 years

First QC Date

May 20, 2022

Last Update Submit

December 3, 2024

Conditions

Keywords

Autism; MRI;Addictive disorders

Outcome Measures

Primary Outcomes (1)

  • Blood Oxygene Level Dependent (BOLD) MRI signal

    Measurement in fMRI of the BOLD signal for each condition (interest, addiction, social) will be carried out in order to highlight the possible alterations of the reward system, in particular at the level of the striatum in terms of cerebral activation for each of the groups of subjects. (FAD, ASD and HV).

    At inclusion

Secondary Outcomes (2)

  • Tolerance to an MRI examination for FAD with overweight or obesity

    At inclusion

  • Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients

    At inclusion

Study Arms (3)

Autism Spectrum Disorder

EXPERIMENTAL

Characterized by two main diagnostic criteria: a socio-emotional deficit via a defect in communication and social reciprocity, and a behavioral deficit which manifests itself in repetitive behavioral patterns (stereotypes), restricted interests and/or activities.

Diagnostic Test: MRIDiagnostic Test: EEG

Food Addictive Disorders

ACTIVE COMPARATOR

Characterized by regroup substance use disorders and behavioral addictions, are characterized in particular by the repeated occurrence of compulsive behavior and impaired social functioning

Diagnostic Test: MRIDiagnostic Test: EEG

Healthy volonteers

PLACEBO COMPARATOR

Adult without neurological and psychiatric history, absence of progressive somatic pathologies or with vital risk.

Diagnostic Test: MRIDiagnostic Test: EEG

Interventions

MRIDIAGNOSTIC_TEST

an fMRI measurement of the BOLD physiological signal for sensory responses

Also known as: Functionnal MRI
Autism Spectrum DisorderFood Addictive DisordersHealthy volonteers
EEGDIAGNOSTIC_TEST

These tests, through videos with a social or non-social content (human presence or absence on the stereoscopic projection), will allow us to study two types of sensorialities (visual and interoceptive). Thus, it will be possible to obtain inter- and exteroceptive profiles of the participants, a direct reflection of the processing of the internal bodily sensations of the body.

Also known as: Electro Encephalography
Autism Spectrum DisorderFood Addictive DisordersHealthy volonteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Arm A ˗ Concerning ASD patients: Adult carrying the diagnosis of ASD (DSM-5, ADOS, ADI-R criteria)
  • Arm B ˗ Concerning FAD patients: Adult diagnosed with FA presenting with food addiction (DSM-5, YFAS 2.0, BES \>= 18 criteria).
  • Arm C ˗ Concerning healthy volunteers : Adult with no neurological and psychiatric history , absence of progressive somatic pathologies or with vital risk.
  • For all participants:
  • Age greater than or equal to 18 years old
  • Without intellectual delay (IQ \> 70).
  • Able to understand and apply the instruction when an active task is proposed, according to the estimate of the investigator.
  • Free, express, informed and written consent of the participant.
  • Participant affiliated to a social security scheme

You may not qualify if:

  • Neuromotor disorders.
  • Visual disturbances not corrected or incompatible with MRI.
  • Known epilepsy.
  • Current substance use disorder with emotional distress/significant impact on functional outcome
  • Rare genetic syndrome.
  • Contraindications to MRI (other than body circumference)
  • For women of childbearing age: negative urine or blood pregnancy test
  • Person subject to a measure of judicial protection (safeguard of justice, curatorship, guardianship or family authorization)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Center-Val de Loire Region Autism Resource Center

Tours, 37044, France

RECRUITING

University Addictology Service, Liaison Team and Addictology Care

Tours, 37044, France

RECRUITING

University Hospital, Medical Imaging Service

Tours, 37044, France

RECRUITING

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic Disorder

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Frédéric BRIEND, PhD

    University Hospital,Tours -INSERM U1253 iBrain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Frédéric BRIEND, PhD

CONTACT

Coralie TAILLEBUIS, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Pilot study, monocentric open in three parallel groups (ASD, AD and healthy volunteers).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2022

First Posted

May 25, 2022

Study Start

July 27, 2023

Primary Completion (Estimated)

July 27, 2026

Study Completion (Estimated)

January 27, 2027

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations